These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
674 related articles for article (PubMed ID: 1769259)
1. [Elective-selective Warren splenorenal shunt operation. Prognosis of liver function and esophageal varices hemorrhage after repeat sclerotherapy in liver cirrhosis]. Paquet KJ; Lazar A; Mercado MA; Gad HA Chirurg; 1991 Nov; 62(11):794-8; discussion 798-9. PubMed ID: 1769259 [TBL] [Abstract][Full Text] [Related]
2. [Surgical measures in recurrent hemorrhage from esophageal and gastric varices after sclerotherapy--a prospective study]. Paquet KJ; Lazar A; Gad HA Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():397-402. PubMed ID: 1983579 [TBL] [Abstract][Full Text] [Related]
3. [Narrow-lumen mesocaval interposition shunt in liver cirrhosis and recurrent esophageal varices hemorrhage. Standard surgery of the future in failure of sclerotherapy?]. Paquet KJ; Lazar A; Kuhn R Dtsch Med Wochenschr; 1995 May; 120(20):707-12. PubMed ID: 7758409 [TBL] [Abstract][Full Text] [Related]
4. [Surgical approach to posthepatitic cirrhotic patient today]. Meriggi F; Forni E G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983 [TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment of portal hypertension]. Wolff M; Hirner A Zentralbl Chir; 2005 Jun; 130(3):238-45. PubMed ID: 15965877 [TBL] [Abstract][Full Text] [Related]
7. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. Orloff MJ; Orloff MS; Orloff SL; Rambotti M; Girard B J Am Coll Surg; 1995 Mar; 180(3):257-72. PubMed ID: 7874335 [TBL] [Abstract][Full Text] [Related]
15. [Interdisciplinary management of portal hypertension: status of portosystemic shunt operations]. Häring R Zentralbl Chir; 1995; 120(2):95-102. PubMed ID: 7709669 [TBL] [Abstract][Full Text] [Related]
16. Calibrated portacaval H-graft shunt in variceal hemorrhage. Long-term results. Fernandez-Aguilar JL; Bondia Navarro JA; Santoyo Santoyo J; Suarez-Muñoz MA; Perez-Daga A; Ramirez Plaza C; Mera Velasco S; de la Fuente Perucho A Hepatogastroenterology; 2003; 50(54):2000-4. PubMed ID: 14696452 [TBL] [Abstract][Full Text] [Related]
17. [The fate of Warren's splenorenal shunt in the era of sclerotherapy]. Cuénoud PF; Crivelli N; Broennimann B; Mosimann F Schweiz Med Wochenschr; 1991 Jun; 121(25):948-50. PubMed ID: 1862310 [TBL] [Abstract][Full Text] [Related]
18. Analysis of a prospective series of 100 mesocaval interposition shunts for bleeding portal hypertension. Paquet KJ; Mercado MA; Kalk JF; Koussouris P; Siemens F; Müting D Hepatogastroenterology; 1990 Feb; 37(1):115-20. PubMed ID: 2312035 [TBL] [Abstract][Full Text] [Related]
19. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver. Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525 [TBL] [Abstract][Full Text] [Related]
20. [Portosystemic shunts in the treatment of bleeding esophageal varices in cirrhotic patients: between sclerotherapy and transplantation]. Gozzetti G; Cavallari A; Mazziotti A; Recordare A; Bellusci R; Nardo B; De Raffele E; Vivarelli M; Camillò B Minerva Chir; 1996 Nov; 51(11):887-95. PubMed ID: 9072715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]